Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion type Assertion NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_head.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion evidence source_evidence_literature NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion SIO_000772 16982741 NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion wasDerivedFrom befree-20150227 NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion wasGeneratedBy ECO_0000203 NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.